Vanda Pharmaceuticals (VNDA) Net Income (QoQ) (2010 - 2026)
Vanda Pharmaceuticals (VNDA) Net Income (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - |
| 2 | Nanobiotix | 1,924.26 Bn | 1,924.20 Bn | - |
| 3 | Akari Therapeutics | 975.59 Bn | 975.59 Bn | - |
| 4 | BeOne Medicines | 472.11 Bn | 467.32 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.89 Bn | 114.65 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.93 Bn | 61.18 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.83 Bn | 62.83 Bn | - |
| 8 | Argenx Se | 55.82 Bn | 50.63 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.49 Bn | 37.49 Bn | - |
| 10 | Vanda Pharmaceuticals | 314.54 Mn | 112.23 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 65.63% |
| Dec 31, 2025 | -525.00% |
| Sep 30, 2025 | 16.91% |
| Jun 30, 2025 | 7.82% |
| Mar 31, 2025 | -504.88% |
| Dec 31, 2024 | 8.76% |
| Sep 30, 2024 | -18.28% |
| Jun 30, 2024 | -8.97% |
| Mar 31, 2024 | -73.40% |
| Dec 31, 2023 | -1,845.26% |
| Sep 30, 2023 | -90.82% |
| Jun 30, 2023 | -53.78% |
| Mar 31, 2023 | -52.95% |
| Dec 31, 2022 | 110.40% |
| Sep 30, 2022 | 25.91% |
| Jun 30, 2022 | 140.07% |
| Mar 31, 2022 | -191.33% |
| Dec 31, 2021 | -8.34% |
| Sep 30, 2021 | -20.00% |
| Jun 30, 2021 | 11.60% |